NEISVAC-C

This brand name is authorized in Austria, Canada, Cyprus, Estonia, France, Ireland, Lithuania, Malta, Netherlands, New Zealand, Poland, Spain.

Active ingredients

The drug NEISVAC-C contains one active pharmaceutical ingredient (API):

1
UNII H2W22AGF1P - NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN
 
Read more about Meningococcal serogroup C polysaccharide vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07AH07 Meningococcus C, purified polysaccharides antigen conjugated J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines
Discover more medicines within J07AH07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02245057
EE Ravimiamet 1355767, 1355778
ES Centro de información online de medicamentos de la AEMPS 64096
FR Base de données publique des médicaments 69261547
LT Valstybinė vaistų kontrolės tarnyba 1009819, 1037215, 1037216
MT Medicines Authority MA505/07801
NL Z-Index G-Standaard 14686104
NL Z-Index G-Standaard, PRK 62235
NZ Medicines and Medical Devices Safety Authority 11388
PL Rejestru Produktów Leczniczych 100216990

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈